Preparation and Evaluation of Long-Acting Injectable Levocetirizine Prodrug Formulation
<b>Background/Objectives</b>: Levocetirizine (LCZ) is a second-generation antihistamine with minimal central nervous system effects. However, its short half-life necessitates daily dosing, potentially reducing adherence in pediatric populations. This study aimed to develop a long-acting...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/806 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|